NCT01169142

Study of Vitamin D in the Severely Mentally Ill

A Pilot Study of Vitamin D Supplementation in Bronx Psychiatric Patients

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 40 (actual)
• Sponsor: Bronx Psychiatric Center · Other Government
• Sex: All
• Age: 19 Years – 70 Years
• Healthy volunteers: Not accepted

Summary

Supplementation of Vitamin D in those with low levels will increase the level and result in some improvement in health and psychopathology measures.

Detailed description

Subjects with levels of Vitamin D between 7ng/ml and 30ng/ml will, after signing consent forms, be randomly assigned to either start immediately on Vitamin D for three months or to start after a delay of three months. Those with levels below 7gn/ml will start immediately. All will be evaluated monthly with blood tests, PANSS, movement disorder ratings and information on health and progress from the clinical chart.

Conditions

• Schizophrenia
• Schizoaffective Disorder

Interventions

Type	Name	Description
DIETARY_SUPPLEMENT	Vitamin D3	50,000 units of Vitamin D3 weekly
DIETARY_SUPPLEMENT	Vitamin D3	Vitamin D3 50,000 units weekly

Timeline

• Start date: 2010-01-01
• Primary completion: 2014-06-01
• Completion: 2015-12-01
• First posted: 2010-07-26
• Last updated: 2018-07-19

Locations

1 site across 1 country: United States